NARS-3' is an orally active reversible xanthine oxidase (XO) inhibitor with the IC50 of 21.01 µM. NARS-3' can competitively inhibit XO activity and reduce uric acid production. NARS-3' can reduce renal damage in hyperuricemia mice. NARS-3' can be used for the study of hyperuricemia[1].
Molecular Weight:
374.30
CAS Number:
[2702589-46-4]
Formula:
C15H11NaO8S
Target:
Xanthine Oxidase
Application Notes:
MCE Product type: Reference compound1
* VAT and and shipping costs not included. Errors and price changes excepted